Gilead Sciences's most recent trend suggests a bearish bias. One trading opportunity on Gilead Sciences is a Bear Call Spread using a strike $106.00 short call and a strike $111.00 long call offers a potential 21.65% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $106.00 by expiration. The full premium credit of $0.89 would be kept by the premium seller. The risk of $4.11 would be incurred if the stock rose above the $111.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Gilead Sciences is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Gilead Sciences is bearish.
The RSI indicator is at 65.67 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Meet 5 Top Biotech Stocks Holding Up In Shaky Market
Sat, 13 Dec 2014 13:02:00 GMT
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Fri, 12 Dec 2014 16:44:40 GMT
Gilead Sciences: Hep-C Scripts Go Down to the Wire
Fri, 12 Dec 2014 14:56:00 GMT
Philadelphia transit system sues Gilead Sciences over $1,000-a-pill drug
Thu, 11 Dec 2014 22:47:00 GMT
How Can Drugmakers Handle New Pricing Pressures?
Thu, 11 Dec 2014 22:38:00 GMT
Also on Market Tamer…
Follow Us on Facebook